DRG 488 Overview

DRG 488 covers hospital admissions for knee procedures when the principal diagnosis is not an infection and the case includes at least one Complication or Comorbidity or Major Complication or Comorbidity. This Diagnosis-Related Group groups resources used for surgical knee interventions such as arthroplasty, revision, and certain major debridements when there is additional clinical complexity. It is important for Centers for Medicare & Medicaid Services inpatient payment because relative resource intensity and allowable payment are influenced by the presence of Complication or Comorbidity or Major Complication or Comorbidity. Accurate coding of diagnoses and procedures determines assignment to this Diagnosis-Related Group and thus affects Medicare reimbursement.

• Perioperative blood management and transfusion-sparing strategies: randomized or pragmatic studies testing protocols such as preoperative anemia optimization, intraoperative blood conservation techniques, and restrictive transfusion thresholds in patients undergoing knee procedures without infection, including total or partial knee arthroplasty and complex arthroscopic reconstructions. These trials focus on the immediate surgical period and enroll typical inpatient populations (older adults, patients with comorbid cardiovascular disease or chronic kidney disease) to determine effects on perioperative morbidity, length of stay, and resource use. Results inform clinicians about safe approaches to minimize transfusions and help payers and hospitals reduce costs and complications tied to blood product use and extended hospital stays.
• Comparative effectiveness studies of implant and fixation strategies or surgical approaches: head-to-head trials or large observational registries comparing different prosthesis designs, cemented versus cementless fixation, or minimally invasive versus standard surgical approaches for degenerative knee disease and complex reconstructive cases. These studies enroll patients indicated for inpatient knee procedures, often stratified by age, bone quality, and baseline functional status, to evaluate outcomes such as early complication rates, need for revision, functional recovery, and readmission within 30–90 days. Findings are directly relevant to surgeons choosing operative technique and implants and to payers assessing value, reimbursement policies, and long-term cost implications of device selection.
• Post-discharge rehabilitation and bundled-care outcomes research: randomized trials or care-pathway evaluations comparing inpatient-plus-outpatient rehabilitation bundles, accelerated discharge with home-based physical therapy, or enhanced recovery after surgery (ERAS) protocols focusing on functional recovery, opioid use, and 30–90 day readmissions among patients who had noninfected knee procedures. The population includes typical inpatient cohorts such as older adults and those with multimorbidity who are at risk for delayed mobility or adverse post-acute events; studies measure patient-reported function, complications, and total episode-of-care costs. This evidence helps hospitals and payers design discharge planning, rehabilitation benefits, and bundled payment models that optimize recovery while controlling post-acute expenditure and readmission risk.